168
J. W. Palko et al. / Tetrahedron: Asymmetry 24 (2013) 165–168
Kwasnieski, O.; Najera, F.; Delouvrie, B.; Marek, I.; Derat, E.; Goddard, J.-P.;
Malacria, M.; Fensterbank, L. Chem. Asian J. 2011, 6, 1825.
10. (a) Reggelin, M.; Weinberger, H.; Spohr, V. Adv. Synth. Catal. 2004, 346, 1295;
(b) Klunder, J. M.; Sharpless, K. B. J. Org. Chem. 1987, 52, 2598.
11. Guerrero-de la Rosa, V.; Ordoñez, M.; Alcudia, F.; Llera, J. M. Tetrahedron Lett.
1985, 36, 4889.
from (SS,SS)-1,1-bis(p-tolylsulfinyl)methane. This route is also ame-
nable to the preparation of any mid-chain cyclopropyl fatty acid in
enantiopure form and is particularly well-suited to the introduc-
tion of isotopic labels at any desired position either as mass labels
or as mechanistic probes. In addition, the door has been opened to
the construction of artificial lipid membrane assemblies bearing
mid-chain chirality.
We are currently preparing analogues of 1 to aid in the elucida-
tion of the mechanism of enzymatic cyclopropane desaturation
and structure–toxicity relationships and our results will be re-
ported in due course.
12. Experimental data for 7: Rf 0.25 (20% EtOAc in hexane, UV, KMnO4).
½
a 2D5
ꢂ
¼ þ136:7 (c 0.48, CHCl3). 1H NMR (CDCl3, 400 MHz): d 7.64 (d, J = 8 Hz,
2H), 7.42 (d, J = 8 Hz, 2H), 7.24 (d, J = 8 Hz, 2H), 7.05 (d, J = 8 Hz), 5.80 (ddt,
J = 17.4, 10.4, 6.6 Hz, 1H), 5.00 (ddd, J = 17.2, 3.86, 1.6 Hz, 1H), 4.94 (ddd,
J = 10.0, 2.0, 1.2 Hz, 1H), 4.51 (m, 1H), 3.94 (d, J = 2.0 Hz, 1H), 3.35 (d, J = 0.8 Hz,
1H), 2.49 (s, 3H), 2.38 (s, 3H), 2.02 (q, J = 7.6 Hz), 1.86 (m, 1H), 1.70 (s, 1H),
1.41–1.09 (m, 10H). 13C NMR (CDCl3, 100 MHz): d 142.2, 141.7, 139.9, 139.0,
138.5, 130.3, 130.3, 129.5, 124.6, 123.8, 114.2, 91.9, 67.0, 34.9, 33.7, 29.2, 28.9,
28.9, 28.8, 25.2, 21.5, 21.3. IR (NaCl plate, cmꢁ1): 3376, 3054, 2926, 2855, 1912,
1640, 1595, 1493, 1453, 1400, 1179, 1083, 1050, 909, 811, 732. HRMS (ESI): m/
z Calcd for C25H35O3S2: 447.2028 (M+H+). Found: 447.2017.
Acknowledgments
13. Best results were obtained by storing 4 at 4 °C and using it within a few days.
14. (a) Corey, E. J.; Chaykovsky, M. J. Am. Chem. Soc. 1965, 87, 1353; (b) Li, A.-H.;
Dai, L.-X.; Aggarwal, V. K. Chem. Rev. 1997, 97, 2341.
P.H.B. and J.M.M. thank NSERC (Discovery and RTI programs).
J.M.M. also thanks Canada Foundation for Innovation (Leaders
Opportunity Fund), Ontario Research Fund, and Carleton University
for financial support. J.W.P. thanks Carleton University for financial
support. The authors thank Prof. Jeff Smith and Karl Wasslen for
performing high resolution mass spectrometry analysis.
15. Experimental data for 3: Rf 0.41 (20% EtOAc in PhMe, UV, KMnO4).
½
a 2D5
ꢂ
¼ ꢁ113:3 (c 0.233, CHCl3). 1H NMR (CDCl3, 400 MHz): d 7.58 (d, J = 8 Hz,
2H), 7.37 (d, J = 8 Hz, 2H), 7.23 (d, J = 8 Hz, 2H), 7.07 (d, J = 8 Hz, 2H), 5.81 (m,
J = 17.2, 10.4, 6.4 Hz, 1H), 5.02 (dd, J = 17.2, 1.6 Hz, 1H), 4.96 (dd, J = 10.4,
0.8 Hz, 1H), 2.49 (s, 3H), 2.41 (s, 3H), 2.05 (q, J = 6.8 Hz, 2H), 1.80-1.62 (m, 6H),
1.40–1.25 (m, 9H). 13C NMR (CDCl3, 100 MHz): d 143.1, 142.2, 139.1, 138.9,
138.4, 130.0, 129.8, 126.5, 125.2, 114.2, 62.9, 33.8, 29.6, 29.3, 29.0, 29.0, 28.9,
27.4, 25.0, 21.6, 21.4, 13.2. IR (NaCl plate, cmꢁ1): 3057, 2925, 2854, 1727, 1639,
1596, 1492, 1449, 1399, 1303, 1178, 1084, 1049, 908, 809, 726. HRMS (ESI): m/
z Calcd for C26H34NaO2S2: 465.1892 (M+Na+). Found: 465.1895.
References
16. Experimental data for 9: Rf 0.29 (20% Et2O in hexane). ½a D25
¼ þ54:2 (c 0.273,
ꢂ
1. (a) Christie, W. W. In Topics in Lipid Chemistry; Gunstone, F. D., Ed.; Wiley: NY,
1970; Vol. 1, p 1; (b) Smith, C. R.; Wilson, T. L.; Mikolajczak, K. L. Chem. Ind.
1961, 256; (c) Kleiman, R.; Earle, F. R.; Wolff, I. A. Lipids 1969, 4, 317; (d) Jie, L.
K.; Marcel, S. F.; Chan, M. F. J. Chem. Soc., Chem. Commun. 1977, 3, 78; (e)
Vickery, J. R. J. Am. Oil Chem. Soc. 1980, 57, 87; (f) Berry, S. K. Lipids 1980, 15,
452; (g) Ralaimanarivo, A.; Gaydou, E. M.; Bianchini, J. P. Lipids 1982, 17, 1; (h)
Fisher, G. S.; Cherry, J. P. Lipids 1983, 18, 589.
2. (a) Buist, P. H. Nat. Prod. Rep. 2004, 21, 249; (b) Buist, P. H. Tetrahedron:
Asymmetry 2004, 15, 2779; (c) Buist, P. H. Nat. Prod. Rep. 2007, 24, 1110.
3. Flowers, M. T.; Ntambi, J. M. Curr. Opin. Lipidol. 2008, 19, 248.
4. (a) Bhar, P.; Reed, D. W.; Covello, P. S.; Buist, P. H. Angew. Chem., Int. Ed. 2012,
51, 6686; (b) Lee, M.; Lenman, M.; Banas, A.; Bafor, M.; Singh, S.; Schweizer, M.;
Nilsson, R.; Liljenberg, C.; Dahlqvist, A.; Gummeson, P.; Sjödahl, S.; Green, A.;
Stymne, S. Science 1998, 280, 915; (c) Reed, D. W.; Polichuk, D. R.; Buist, P. H.;
Ambrose, S. J.; Sasata, R. J.; Savile, C. K.; Ross, A. R. S.; Covello, P. S. J. Am. Chem.
Soc. 2003, 125, 10635.
CHCl3). 1H NMR (CDCl3, 400 MHz): d 7.51 (d, J = 8 Hz, 2H), 7.30 (d, J = 8 Hz, 2H),
5.82 (ddd, J = 17.2, 10.0, 6.8 Hz, 1H), 5.01 (ddd, J = 17.2, 3.6, 1.6 Hz), 4.98 (ddd,
J = 10.0, 3.6, 1.6 Hz, 1H), 2.43 (s, 3H), 2.05 (q, J = 6.8 Hz, 2H), 1.65-1.55 (m, 3H),
1.43–1.24 (m, 25H), 0.91 (t, J = 6.8 Hz, 3H), 0.44 (t, J = 6.4 Hz, 1H). 13C NMR
(CDCl3, 100 MHz): d 141.4, 139.8, 139.1, 129.5, 125.1, 114.2, 44.3, 33.8, 31.8,
29.8, 29.4, 29.4, 29.3, 29.2, 29.2, 29.0, 28.9, 28.3, 27.4, 26.2, 22.6, 21.4, 18.8,
14.7, 14.1. IR (NaCl plate, cmꢁ1): 2926, 2854, 2361, 1640, 1493, 1465, 1085,
1052, 908, 809. HRMS (ESI): m/z Calcd for C27H45OS: 417.3191 (M+H+). Found:
417.3181.
17. We did not observe cleavage and alkylation of the less hindered sulfoxide.
However, this reaction generates several byproducts, all of which are highly
non-polar and challenging to separate. Fortunately, 9 was the first to elute
from the column during flash chromatography and was isolated cleanly.
18. Krapcho, A. P.; Larson, J. R.; Eldridge, J. M. J. Org. Chem. 1977, 42, 3749.
19. Travis, B. R.; Narayan, R. S.; Borhan, B. J. Am. Chem. Soc. 2002, 124, 3824.
20. (a) Marshall, J. A.; Garofalo, A. W.; Sedrani, R. C. Synlett 1992, 643; (b) Marshall,
J. A.; Garofalo, A. W. J. Org. Chem. 1993, 58, 3675.
5. Stuart, L. J.; Buck, J. P.; Tremblay, A. E.; Buist, P. H. Org. Lett. 2006, 8, 79. and
references cited therein.
6. Coxon, G. D.; Al-Dulayymi, J. R.; Baird, M. S.; Knobl, S.; Roberts, E.; Minnikin, D.
E. Tetrahedron: Asymmetry 2003, 14, 1211.
7. Lou, Y.; Horikawa, M.; Kloster, R. A.; Hawryluk, N. A.; Corey, E. J. J. Am. Chem.
Soc. 2004, 126, 8916.
21. Simmons, H. E.; Smith, R. D. J. Am. Chem. Soc. 1959, 81, 4256.
22. Al-Dulayymi, J. R.; Baird, M.; Roberts, E. Chem. Commun. 2003, 228.
23. Gassman, P. G.; Hodgson, P. K. G.; Balchunis, R. J. J. Am. Chem. Soc. 1976, 98,
1275.
8. Abrahamovitch, A.; Fensterbank, L.; Malacria, M.; Marek, I. Angew. Chem., Int.
Ed. 2008, 47, 6865.
24. NMR data corresponded with literature values. See: Knothe, G. Lipids 2006, 41,
393.
9. (a) Goddard, J.-P.; Gomez, C.; Brebion, F.; Beauvière, S.; Fensterbank, L.;
Malacria, M. Chem. Commun. 2007, 2929; (b) Brebion, F.; Goddard, J. P.;
Fensterbank, L.; Malacria, M. Synthesis 2005, 2449; (c) Brebion, F.; Delouvrié, B.;
Nàjera, F.; Fensterbank, L.; Malacria, M.; Vaissermann, J. Angew. Chem., Int. Ed.
2003, 42, 5342; (d) Delouvrié, B.; Nàjera, F.; Fensterbank, L.; Malacria, M. J.
Organomet. Chem. 2002, 643, 130; (e) Brebion, F.; Vincent, G.; Chelli, S.;
25. (a) Tocanne, J. F. Tetrahedron 1972, 28, 363; (b) Tocanne, J. F.; Bergmann, R. G.
Tetrahedron 1972, 28, 373.
26. Sakaguchi, S.; Yamamoto, Y.; Sugimoto, T.; Yamamoto, H.; Ishii, Y. J. Org. Chem.
1999, 64, 5954.
27. Watson, S. C.; Eastham, J. F. J. Organomet. Chem. 1967, 9, 165.
28. Stuart, L. J.; Buist, P. H. Tetrahedron: Asymmetry 2004, 15, 401.